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Abstract 4 
Background: Cerebral bypass surgery remains an integral part of the treatment of complex skull 5 
base tumors and unclippable aneurysms.  6 
Objective: The authors retrospectively analyzed a single-surgeon experience using a high-flow 7 
submandibular–infratemporal saphenous vein graft bypass technique after carotid artery sacrifice 8 
in the resection of complex skull base tumors and carotid isolation in unclippable aneurysms. 9 
Methods: Data on indications, surgical technique, bypass patency, complications, and outcome 10 
were collected for patients treated with adjunctive submandibular high-flow bypass for skull base 11 
lesions. 12 
Results: Eleven patients (age range: 13–77 years) were treated for various skull base lesions: 4 13 
patients were treated for skull base tumors with resection of the ICA, 6 were treated for 14 
aneurysms not amenable to clipping, and one was treated for invasive Mucor infection. Using a 15 
saphenous vein graft, a high-flow bypass was created from the high cervical internal carotid 16 
artery (ICA) or external carotid artery to ICA or middle cerebral artery by means of a 17 
submandibular–infratemporal route. Postoperative computed tomography angiography indicated 18 
bypass patency in 10/11 patients. There was no operative mortality. Follow-up of up to 12 years 19 
(mean 57 months) was achieved. 20 
Conclusion: Direct high-flow submandibular–infratemporal interpositional saphenous vein 21 
bypass graft is an effective and durable technique for the treatment of complex skull base lesions 22 
where internal carotid artery revascularization is indicated. 23 
 24 
Keywords: Extracranial–intracranial bypass; carotid bypass; radial artery; saphenous vein 25 
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Introduction  28 
Extracranial–intracranial bypass techniques remain important in the surgical treatment of 29 
complex intracranial aneurysms and skull base tumors.1-5 Specifically, giant and fusiform 30 
aneurysms that are amenable to neither clipping nor endovascular treatment may require 31 
proximal vessel occlusion and a bypass procedure for revascularization purposes. Skull base 32 
tumors involving the carotid artery may be treated with the goal of gross total resection by 33 
internal carotid artery (ICA) sacrifice.6 In these instances, an extracranial–intracranial bypass 34 
offers revascularization of the distal vascular tree.  We recently reviewed the current indications 35 
for performing high-flow bypass.7 In the past decades, high-flow bypass techniques have 36 
undergone a number of modifications aimed at rendering the procedure safe and improving the 37 
long-term bypass rate.1, 8-12 In addition to modifications involving preoperative evaluation, 38 
monitoring, and neuroanesthesia, these modifications relate largely but not exclusively to donor 39 
graft (saphenous vein versus radial artery), graft harvesting (open versus endoscopic), 40 
anastomosis (interrupted versus noninterrupted microsutures versus excimer laser-assisted 41 
nonocclusive anastomosis), and location and fashion of tunneling of graft (preauricular versus 42 
postauricular route).8, 9, 13-16  Most current high-flow bypass techniques involve either a radial 43 
artery or a saphenous vein graft using one of the following revascularization points: cervical-to-44 
petrous ICA, petrous-to-supraclinoid ICA, cervical-to-supraclinoid ICA, and cervical-to-M2 45 
bypass.8, 10, 12, 17 46 
In all but the petrous–supraclinoid routes, special attention must be paid to the 47 
subcutaneous tunneling of the saphenous vein graft, with both preauricular and postauricular 48 
routing mentioned in the literature.8 Because tunneling affects graft length and may thus impact 49 
long-term bypass patency, the senior author (WTC) has previously described a direct 50 
submandibular–infratemporal bypass technique that eliminates the need for tunneling.18 In the 51 
early cases using this technique, the zygoma was detached and reflected inferiorly with the 52 
masseter and temporalis muscles to allow a bone trough to be made at the middle fossa cranial 53 
base. This provided room for the graft and helped avoid compromising the graft with mandibular 54 
movement.18 This technique has since been modified to eliminate the need for an osteotomy of 55 
the zygoma.  Instead, a small middle fossa burr hole is created for the graft at the base lateral to 56 
the foramen ovale and anterior to the temporomandibular joint.  This allows the graft to be 57 
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In this study, we analyzed our long-term experience with patients who underwent the 59 
direct submandibular–infratemporal high-flow bypass technique, with special emphasis on 60 




Patients were identified via an Institutional Review Board-approved retrospective data 65 
review spanning the years from 1999 to 2011. All patients operated on by the senior author 66 
(WTC) with a direct submandibular–infratemporal high-flow bypass were included; some 67 
patients have been described in previous publications of the technical aspects of the technique.18-68 
20 Indications, technical aspects, clinical and radiological outcome, and bypass patency were 69 
analyzed. Perioperative morbidity and mortality over a 30-day period were noted. All patients 70 
were monitored with computed tomography angiography (CTA) or magnetic resonance 71 
angiography (MRA) within the first 48 hours and again at 6 months, after which bypass patency 72 
was evaluated yearly.  73 
 74 
Surgical Technique 75 
The surgical technique has been previously described elsewhere in detail.18-20 In short, a 76 
standard frontotemporal craniotomy is performed, followed by wide splitting of the sylvian 77 
fissure. The proximal ICA or an M2 or M3 branch is dissected out as a recipient vessel. A high-78 
speed drill is used to make a small craniectomy at the base of the middle fossa lateral to the 79 
foramen ovale to accommodate the tunneled saphenous vein graft. The carotid bifurcation and 80 
the external carotid artery (ECA) and ICA are exposed in the neck (Figure 1). The saphenous 81 
vein graft is tunneled from the neck incision into the intracranial cavity through the 82 
submandibular–infratemporal tunnel using a 14-French chest tube. After a dose of 5000 units of 83 
intravenous heparin is administered, the cervical ECA is ligated as high in the neck as possible. 84 
The distal end of the cervical ECA is mobilized inferiorly, and an end-to-end anastomosis is 85 
performed between the distal cervical ECA and the proximal end of the saphenous vein graft 86 
using 7–0 Prolene interrupted sutures. The distal portion of the vein graft is then brought up into 87 
the intracranial cavity through the submandibular–infratemporal tunnel, and an end-to-side 88 
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Autologous pericranium is harvested to facilitate the dura mater closure at the cranial base 90 
around the graft. Intraoperative bypass patency is assessed by Doppler ultrasound and/or in more 91 
recent cases ICG (indocyanine green) videoangiography. Early postoperative patency was 92 
confirmed with CTA or MRA in all cases (Figure 2). 93 
 94 
Results 95 
 A total of 11 patients (4 female, 7 male) underwent a high-flow direct submandibular–96 
infratemporal saphenous vein graft bypass procedure. Of these, 4 patients were treated for skull 97 
base tumors with resection of the ICA, 6 were treated for aneurysms not amenable to clipping, 98 
and one was treated for invasive Mucor infection, as part of an attempted radical salvage 99 
debridement operation (Table 1). The average age of the patient at surgery was 54 years (range 100 
13–77 years). 101 
 All of the patients demonstrated patency of the graft at the time of insertion.  Ten of 11 102 
patients demonstrated long-term patency in follow-up (mean 57 months; Table 1).  One patient 103 
(patient 7), a diabetic man with medically refractory Mucor infection, developed delayed 104 
thrombosis of his graft after 48 hours. 105 
None of the patients had permanent clinical deterioration related to their revascularization 106 
procedure.  Three patients died during follow-up related to the natural history of their underlying 107 
disease.  No patient developed specific complications of the surgical donor site.  Two patients 108 
developed surgically related infections (sepsis, pneumonia), which were treated without 109 
sequelae.  Deep venous thrombosis occurred in two patients, who were treated with 110 
anticoagulation therapy.  Two patients developed gastrointestinal-related problems, one bowel 111 
ischemia that required resection and a gastrointestinal bleed, which was treated with medical 112 
therapy.  A right subdural hematoma ipsilateral to the site of surgery occurred in one patient, 113 




Our case series of long-term outcome of bypasses performed by direct submandibular–118 
infratemporal route validates the role of this approach as a safe route offering a true alternative to 119 
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patency of the graft postoperatively.  This was a young diabetic patient with medically refractory 121 
relentless mucormycosis infection in whom a radical debridement operation was performed. This 122 
is similar to initial intraoperative patency rates seen in other series using the saphenous vein 123 
graft.16  124 
 125 
Selection of Candidates for Bypass 126 
The issue of universal versus selective revascularization when considering ICA sacrifice 127 
remains controversial.  The senior author prefers to use a very selective approach in choosing 128 
those patients who have undergone carotid sacrifice in need of high-flow replacement.21 129 
Suitability is evaluated with a balloon test occlusion (BTO), paired with CT perfusion testing 130 
with acetazolamide challenge to assess cerebrovascular reserve.22 Ischemic symptoms evident 131 
while performing the BTO or evidence of ischemia during CT perfusion imaging are a strict 132 
indication for carotid revascularization as used in this series; however, false-negative results can 133 
result in significant ischemic complications after ICA sacrifice.23-25  Failure to adequately predict 134 
which patients will develop delayed neurological complications after carotid sacrifice and the 135 
risk of de novo aneurysm formation have led many surgeons to be generous with the indications 136 
for bypass surgery after carotid sacrifice. The risk of carotid sacrifice without revascularization, 137 
specifically the reported mortality rate of about 7% and a neurological morbidity rate of up to 138 
17%, should be weighed against the complication rate of bypass surgery, for which a morbidity 139 
rate of 3–7% and no significant mortality have been reported.21, 26, 27 The senior author has 140 
therefore adopted the approach of also choosing to revascularize young patients harboring benign 141 
disease who have a significant life expectancy.   142 
 143 
Technical Considerations 144 
It is clear that meticulous attention to all technical details is necessary to achieve an 145 
optimal long-term bypass patency rate. Modifications over the years have eliminated aspects that 146 
may potentially compromise bypass patency. Tunneling has the potential to constrict the bypass 147 
graft in its subcutaneous plane either by head movement, scarring, or the use of glasses.1, 8 The 148 
technique developed by the senior author eliminates the need for subcutaneous tunneling and 149 
provides a direct plane for the bypass graft on its submandibular-to-infratemporal route. This 150 
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nature in young women, making both pre- and postauricular routes for the bypass graft difficult 152 
in this patient population because of graft length. The direct submandibular–infratemporal route 153 
is much shorter and provides a real alternative in these cases. The shorter route in our technique 154 
may also be an advantage in achieving long-term bypass patency, because longer bypass grafts 155 
may have a high failure rate caused by thrombosis of a lengthy graft.1, 20 The senior author often 156 
chooses a saphenous vein graft as in the present series, as it has the benefit of greater length and 157 
enables a choice for graft selection when trying to optimize the recipient–donor vessel caliber 158 
match.  The specific segment of the saphenous vein is chosen after review of the caliber of the 159 
vein throughout its course in the leg by preoperative ultrasonography. End-to-end anastomosis is 160 
preferred from the external carotid artery donor site, when possible, to promote graft patency by 161 
reducing turbulent flow. This also prevents kinking of the vessel during head movement.  In 162 
addition, the proximal end is anastamosed to the ECA if possible to avoid cross-clamping the 163 
ICA during this portion of the procedure.  We have experienced no complications with end-to-164 
end bypass and sacrifice of the ECA supply to the face. In our submandibular–infratemporal 165 
technique, attention is paid to a number of surgical details. Because the hole situated in the 166 
middle fossa needs to be large enough to avoid kinking of the graft by head movements, the hole 167 
is created extradurally with minimal temporal lobe retraction. No morbidity has been related to 168 
temporal lobe edema after the procedure. This technique also eliminates the need for a zygomatic 169 
osteotomy, and the insertions of the temporalis and masseter muscles are left intact, which 170 
affects cosmetic outcome. Finally, care must be taken during the submandibular passage not to 171 
injure any neural or vascular structure in the region (i.e., lingual nerve, inferior alveolar nerve, 172 
hypoglossal nerve, or internal maxillary artery). Passage of the chest tube is aided by the use of a 173 
tonsil clamp and continuous digital palpation with little or no blunt dissection required. 174 
 175 
Conclusions  176 
Analysis of this series of patients demonstrates the utility of the submandibular high-flow 177 
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Figure Legends 258 
 259 
Figure 1.  The submandibular bypass technique. Illustration showing the cervical-to-supraclinoid 260 
ICA bypass using an interpositional saphenous vein graft. The graft is tunneled through the 261 
submandibular–infratemporal route via a middle fossa craniectomy (shaded region, see inset) 262 
that is located lateral to the foramen ovale. In this example, the graft is anastomosed to the 263 
supraclinoid ICA in an end-to-side fashion. An aneurysm clip is placed just proximal to the 264 
ophthalmic artery takeoff. ICA, internal carotid artery; ECA, external carotid artery; SVG, 265 
saphenous vein graft; OA, ophthalmic artery; FO, foramen ovale. Reprinted with permission 266 
from Couldwell et al.20 267 
 268 
Figure 2.  Representative case (patient 5).  (A) Axial and coronal T1-weighted MR images with 269 
gadolinium enhancement obtained 1 month before resection demonstrating recurrent tumor of 270 
the cavernous sinus and posterolateral orbit. Axial (B) and coronal (C) postoperative CT images 271 
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Sex Age Indication Donor Vessel, 
Recipient Vessel 












R Doppler none 112 
died from recurrent 
disease; 
bypass patent on MRA 
2 M 56 nasopharyngeal carcinoma  





R Doppler DVT, 
HIT, sepsis 
9 
died of systemic disease at 
9 months 









bypass patent on CTA 




R Doppler none 71 
neurologically 
stable/glioma; bypass 
patent on MRA 








bypass patent on MRA 
6 F 69 expanding unruptured  










bypass patent on CTA 
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thrombosed graft death/atrial fibrillation 




L ICG angio MRSA pneumonia 18 
death/withdrawal of care; 
bypass patent  




R Doppler none 70 
neurologically stable; CTA 
incidental stenosis 
 
10 M 74 giant unruptured ICA aneurysm external carotid, 
M2 
R Doppler SDH 63 
neurologically intact; 
bypass patent on CTA 
 




L Doppler none 144 
neurologically intact; 
bypass patent on CTA 
 
CT, computed tomography; CTA, computed tomography angiography; DVT, deep venous thrombosis; HIT, heparin-induced thrombocytopenia; ICA, internal carotid artery; ICG, 
indocyanine green; MCA, middle cerebral artery; MRI, magnetic resonance imaging; MRSA, methicillin-resistant Staphylococcus aureus; SDH, subdural hematoma 
1Several patients have been described in previous publications of the technical aspects of the technique.18-20 
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